Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The polymerase acidic (PA) protein endonuclease domain is a critical component of the influenza virus RNA-dependent RNA polymerase complex, located at the N-terminus of the PA protein. Its primary function is to cleave host pre-mRNAs to generate capped RNA primers via "cap-snatching," which the viral polymerase then uses to initiate synthesis of viral mRNAs. This activity is essential for both transcription and replication of the influenza virus genome. The PA endonuclease is a validated antiviral drug target.
Inhibition of PA endonuclease activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Polymerase Acidic Protein Endonuclease Domain (PA-N).